HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-OCT-13 4NAT TITLE INHIBITORS OF 4-PHOSPHOPANTHETHEINE ADENYLYLTRANSFERASE CAVEAT 4NAT CHIRALITY ERRORS AT C11 AND C17 CHIRAL CENTERS OF LIGAND 2W5 CAVEAT 2 4NAT A 201. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: DEPHOSPHO-COA PYROPHOSPHORYLASE, PANTETHEINE-PHOSPHATE COMPND 5 ADENYLYLTRANSFERASE, PPAT; COMPND 6 EC: 2.7.7.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 196620; SOURCE 4 STRAIN: MW2; SOURCE 5 GENE: COAD, MW1007; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COAD, PANTHETHEINE, PHOSPHOPANTHETHEINE ADENYLYLTRANSFERASE, COABC, KEYWDS 2 CYTOSOLIC, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.D.LAHIRI REVDAT 2 28-FEB-24 4NAT 1 REMARK REVDAT 1 12-MAR-14 4NAT 0 JRNL AUTH B.L.DE JONGE,G.K.WALKUP,S.D.LAHIRI,H.HUYNH,G.NECKERMANN, JRNL AUTH 2 L.UTLEY,T.J.NASH,J.BROCK,M.SAN MARTIN,A.KUTSCHKE, JRNL AUTH 3 M.JOHNSTONE,V.LAGANAS,L.HAJEC,R.F.GU,H.NI,B.CHEN, JRNL AUTH 4 K.HUTCHINGS,E.HOLT,D.MCKINNEY,N.GAO,S.LIVCHAK,J.THRESHER JRNL TITL DISCOVERY OF INHIBITORS OF 4'-PHOSPHOPANTETHEINE JRNL TITL 2 ADENYLYLTRANSFERASE (PPAT) TO VALIDATE PPAT AS A TARGET FOR JRNL TITL 3 ANTIBACTERIAL THERAPY. JRNL REF ANTIMICROB.AGENTS CHEMOTHER. V. 57 6005 2013 JRNL REFN ISSN 0066-4804 JRNL PMID 24041904 JRNL DOI 10.1128/AAC.01661-13 REMARK 2 REMARK 2 RESOLUTION. 1.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 85.4 REMARK 3 NUMBER OF REFLECTIONS : 52871 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2812 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.72 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1401 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 30.86 REMARK 3 BIN R VALUE (WORKING SET) : 0.4770 REMARK 3 BIN FREE R VALUE SET COUNT : 68 REMARK 3 BIN FREE R VALUE : 0.4390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3739 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 195 REMARK 3 SOLVENT ATOMS : 117 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : 0.01000 REMARK 3 B33 (A**2) : 0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.140 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.142 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.535 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4027 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3766 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5449 ; 2.442 ; 2.025 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8716 ; 1.158 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 464 ; 6.942 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 172 ;35.974 ;24.070 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 718 ;16.502 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;23.062 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 614 ; 0.233 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4293 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 860 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 144 ; 0.160 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 2 ; 0.144 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.198 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 90 ; 0.261 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.148 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1856 ; 2.809 ; 3.100 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1855 ; 2.810 ; 3.099 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2311 ; 3.649 ; 4.625 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2171 ; 3.454 ; 3.647 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4NAT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-DEC-13. REMARK 100 THE DEPOSITION ID IS D_1000082968. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55684 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.720 REMARK 200 RESOLUTION RANGE LOW (A) : 24.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.72 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.77 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14 TO 19% POLYETHYLENE GLYCOL 3350 REMARK 280 (PEG 3350), 200 MM AMMONIUM SULFATE, 0.1M PROPIONIC ACID REMARK 280 CACODYLATE BIS-TRIS PROPANE BUFFER, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.47500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.47500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 38.07850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 63.64150 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 38.07850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 63.64150 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 63.47500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 38.07850 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 63.64150 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 63.47500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 38.07850 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 63.64150 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 23720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -137.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 76.15700 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -63.47500 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 39 REMARK 465 ASN A 40 REMARK 465 SER A 41 REMARK 465 LYS A 42 REMARK 465 LYS A 43 REMARK 465 GLU A 44 REMARK 465 ASN B 40 REMARK 465 SER B 41 REMARK 465 LYS B 42 REMARK 465 LYS B 43 REMARK 465 ASN C 40 REMARK 465 SER C 41 REMARK 465 LYS C 42 REMARK 465 LYS C 43 REMARK 465 GLU C 44 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU C 98 CD GLU C 98 OE2 0.074 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 76 CG1 - CB - CG2 ANGL. DEV. = 11.1 DEGREES REMARK 500 VAL A 136 CG1 - CB - CG2 ANGL. DEV. = 11.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 13 65.76 -119.45 REMARK 500 ASN B 65 31.74 -141.35 REMARK 500 PHE B 71 142.76 -172.96 REMARK 500 SER B 72 -104.36 110.52 REMARK 500 ASP C 13 62.36 -118.27 REMARK 500 ASN C 111 103.58 -161.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 2 HIS A 3 148.65 REMARK 500 PHE A 159 LYS A 160 -138.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2W5 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPE A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2W5 B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPE B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP B 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2W5 C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP C 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4NAH RELATED DB: PDB REMARK 900 RELATED ID: 4NAU RELATED DB: PDB DBREF 4NAT A 1 160 UNP P63820 COAD_STAAW 1 160 DBREF 4NAT B 1 160 UNP P63820 COAD_STAAW 1 160 DBREF 4NAT C 1 160 UNP P63820 COAD_STAAW 1 160 SEQRES 1 A 160 MET GLU HIS THR ILE ALA VAL ILE PRO GLY SER PHE ASP SEQRES 2 A 160 PRO ILE THR TYR GLY HIS LEU ASP ILE ILE GLU ARG SER SEQRES 3 A 160 THR ASP ARG PHE ASP GLU ILE HIS VAL CYS VAL LEU LYS SEQRES 4 A 160 ASN SER LYS LYS GLU GLY THR PHE SER LEU GLU GLU ARG SEQRES 5 A 160 MET ASP LEU ILE GLU GLN SER VAL LYS HIS LEU PRO ASN SEQRES 6 A 160 VAL LYS VAL HIS GLN PHE SER GLY LEU LEU VAL ASP TYR SEQRES 7 A 160 CYS GLU GLN VAL GLY ALA LYS THR ILE ILE ARG GLY LEU SEQRES 8 A 160 ARG ALA VAL SER ASP PHE GLU TYR GLU LEU ARG LEU THR SEQRES 9 A 160 SER MET ASN LYS LYS LEU ASN ASN GLU ILE GLU THR LEU SEQRES 10 A 160 TYR MET MET SER SER THR ASN TYR SER PHE ILE SER SER SEQRES 11 A 160 SER ILE VAL LYS GLU VAL ALA ALA TYR ARG ALA ASP ILE SEQRES 12 A 160 SER GLU PHE VAL PRO PRO TYR VAL GLU LYS ALA LEU LYS SEQRES 13 A 160 LYS LYS PHE LYS SEQRES 1 B 160 MET GLU HIS THR ILE ALA VAL ILE PRO GLY SER PHE ASP SEQRES 2 B 160 PRO ILE THR TYR GLY HIS LEU ASP ILE ILE GLU ARG SER SEQRES 3 B 160 THR ASP ARG PHE ASP GLU ILE HIS VAL CYS VAL LEU LYS SEQRES 4 B 160 ASN SER LYS LYS GLU GLY THR PHE SER LEU GLU GLU ARG SEQRES 5 B 160 MET ASP LEU ILE GLU GLN SER VAL LYS HIS LEU PRO ASN SEQRES 6 B 160 VAL LYS VAL HIS GLN PHE SER GLY LEU LEU VAL ASP TYR SEQRES 7 B 160 CYS GLU GLN VAL GLY ALA LYS THR ILE ILE ARG GLY LEU SEQRES 8 B 160 ARG ALA VAL SER ASP PHE GLU TYR GLU LEU ARG LEU THR SEQRES 9 B 160 SER MET ASN LYS LYS LEU ASN ASN GLU ILE GLU THR LEU SEQRES 10 B 160 TYR MET MET SER SER THR ASN TYR SER PHE ILE SER SER SEQRES 11 B 160 SER ILE VAL LYS GLU VAL ALA ALA TYR ARG ALA ASP ILE SEQRES 12 B 160 SER GLU PHE VAL PRO PRO TYR VAL GLU LYS ALA LEU LYS SEQRES 13 B 160 LYS LYS PHE LYS SEQRES 1 C 160 MET GLU HIS THR ILE ALA VAL ILE PRO GLY SER PHE ASP SEQRES 2 C 160 PRO ILE THR TYR GLY HIS LEU ASP ILE ILE GLU ARG SER SEQRES 3 C 160 THR ASP ARG PHE ASP GLU ILE HIS VAL CYS VAL LEU LYS SEQRES 4 C 160 ASN SER LYS LYS GLU GLY THR PHE SER LEU GLU GLU ARG SEQRES 5 C 160 MET ASP LEU ILE GLU GLN SER VAL LYS HIS LEU PRO ASN SEQRES 6 C 160 VAL LYS VAL HIS GLN PHE SER GLY LEU LEU VAL ASP TYR SEQRES 7 C 160 CYS GLU GLN VAL GLY ALA LYS THR ILE ILE ARG GLY LEU SEQRES 8 C 160 ARG ALA VAL SER ASP PHE GLU TYR GLU LEU ARG LEU THR SEQRES 9 C 160 SER MET ASN LYS LYS LEU ASN ASN GLU ILE GLU THR LEU SEQRES 10 C 160 TYR MET MET SER SER THR ASN TYR SER PHE ILE SER SER SEQRES 11 C 160 SER ILE VAL LYS GLU VAL ALA ALA TYR ARG ALA ASP ILE SEQRES 12 C 160 SER GLU PHE VAL PRO PRO TYR VAL GLU LYS ALA LEU LYS SEQRES 13 C 160 LYS LYS PHE LYS HET 2W5 A 201 28 HET EPE A 202 15 HET ADP A 203 27 HET 2W5 B 201 28 HET EPE B 202 15 HET ADP B 203 27 HET 2W5 C 201 28 HET ADP C 202 27 HETNAM 2W5 (1R,2R)-N-(3,4-DICHLOROBENZYL)-2-(4,6- HETNAM 2 2W5 DIMETHOXYPYRIMIDIN-2-YL)CYCLOHEXANECARBOXAMIDE HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETSYN EPE HEPES FORMUL 4 2W5 3(C20 H23 CL2 N3 O3) FORMUL 5 EPE 2(C8 H18 N2 O4 S) FORMUL 6 ADP 3(C10 H15 N5 O10 P2) FORMUL 12 HOH *117(H2 O) HELIX 1 1 THR A 16 THR A 27 1 12 HELIX 2 2 ASP A 28 PHE A 30 5 3 HELIX 3 3 SER A 48 VAL A 60 1 13 HELIX 4 4 LEU A 74 GLY A 83 1 10 HELIX 5 5 ALA A 93 ASN A 111 1 19 HELIX 6 6 SER A 122 SER A 126 5 5 HELIX 7 7 SER A 129 TYR A 139 1 11 HELIX 8 8 PRO A 148 LYS A 160 1 13 HELIX 9 9 THR B 16 THR B 27 1 12 HELIX 10 10 SER B 48 LYS B 61 1 14 HELIX 11 11 LEU B 74 GLY B 83 1 10 HELIX 12 12 ALA B 93 ASN B 111 1 19 HELIX 13 13 SER B 122 SER B 126 5 5 HELIX 14 14 SER B 129 TYR B 139 1 11 HELIX 15 15 PRO B 148 PHE B 159 1 12 HELIX 16 16 THR C 16 THR C 27 1 12 HELIX 17 17 SER C 48 LYS C 61 1 14 HELIX 18 18 LEU C 74 GLY C 83 1 10 HELIX 19 19 ALA C 93 ASN C 111 1 19 HELIX 20 20 SER C 122 SER C 126 5 5 HELIX 21 21 SER C 129 TYR C 139 1 11 HELIX 22 22 PRO C 148 PHE C 159 1 12 SHEET 1 A 5 VAL A 66 GLN A 70 0 SHEET 2 A 5 GLU A 32 VAL A 37 1 N VAL A 35 O HIS A 69 SHEET 3 A 5 ILE A 5 GLY A 10 1 N ILE A 8 O HIS A 34 SHEET 4 A 5 THR A 86 LEU A 91 1 O ILE A 88 N VAL A 7 SHEET 5 A 5 GLU A 115 MET A 120 1 O LEU A 117 N ILE A 87 SHEET 1 B 5 VAL B 66 PHE B 71 0 SHEET 2 B 5 GLU B 32 LEU B 38 1 N ILE B 33 O LYS B 67 SHEET 3 B 5 ILE B 5 GLY B 10 1 N ILE B 8 O HIS B 34 SHEET 4 B 5 THR B 86 LEU B 91 1 O ILE B 88 N VAL B 7 SHEET 5 B 5 GLU B 115 MET B 120 1 O LEU B 117 N ILE B 87 SHEET 1 C 5 VAL C 66 PHE C 71 0 SHEET 2 C 5 GLU C 32 LEU C 38 1 N VAL C 35 O LYS C 67 SHEET 3 C 5 ILE C 5 PRO C 9 1 N ILE C 8 O HIS C 34 SHEET 4 C 5 THR C 86 LEU C 91 1 O ILE C 88 N VAL C 7 SHEET 5 C 5 GLU C 115 MET C 120 1 O LEU C 117 N ILE C 87 CISPEP 1 ASP A 13 PRO A 14 0 0.83 CISPEP 2 ASP B 13 PRO B 14 0 -3.24 CISPEP 3 PHE B 71 SER B 72 0 6.06 CISPEP 4 ASP C 13 PRO C 14 0 1.75 SITE 1 AC1 12 PRO A 9 CYS A 36 PHE A 71 GLY A 73 SITE 2 AC1 12 LEU A 74 LEU A 75 LEU A 103 ASN A 107 SITE 3 AC1 12 HOH A 317 HOH A 329 GLU B 135 TYR B 139 SITE 1 AC2 6 LEU A 74 ASP A 77 LEU A 110 TYR B 139 SITE 2 AC2 6 ARG B 140 ALA B 141 SITE 1 AC3 7 PRO A 9 GLY A 10 SER A 11 PHE A 12 SITE 2 AC3 7 HIS A 19 ARG A 89 HOH A 335 SITE 1 AC4 14 PRO B 9 CYS B 36 PHE B 71 GLY B 73 SITE 2 AC4 14 LEU B 74 LEU B 75 ARG B 89 LEU B 103 SITE 3 AC4 14 MET B 106 ASN B 107 HOH B 323 HOH B 337 SITE 4 AC4 14 GLU C 135 TYR C 139 SITE 1 AC5 6 TYR A 139 ARG A 140 ALA A 141 LEU C 74 SITE 2 AC5 6 ASP C 77 LEU C 110 SITE 1 AC6 5 GLY B 10 SER B 11 PHE B 12 HIS B 19 SITE 2 AC6 5 ARG B 89 SITE 1 AC7 14 GLU A 135 VAL A 136 PRO C 9 CYS C 36 SITE 2 AC7 14 LEU C 38 GLY C 73 LEU C 74 LEU C 75 SITE 3 AC7 14 ARG C 89 MET C 106 ASN C 107 ADP C 202 SITE 4 AC7 14 HOH C 319 HOH C 338 SITE 1 AC8 10 GLY C 10 SER C 11 PHE C 12 HIS C 19 SITE 2 AC8 10 ARG C 89 ARG C 92 TYR C 99 2W5 C 201 SITE 3 AC8 10 HOH C 340 HOH C 342 CRYST1 76.157 127.283 126.950 90.00 90.00 90.00 C 2 2 21 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013131 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007857 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007877 0.00000